SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Bradpalm1 who wrote (12846)8/7/1998 1:47:00 AM
From: VLAD  Read Replies (1) of 23519
 
Bradpalm,

I must confess that tonight you produced the most meaningful post regarding Vivus and it's shareprice. IMO this "lack of forgiveness"
has been repeatedly demonstrated via the continued high short interest AND the fact that whenever Vivus shows a nice move to the upside it is short lived since a lot of money is thrown at it to pound it back down.

Had Wilson called for an analyst meeting back in early November and discussed how moving equipment to the new plant would create a production shortfall and thus lower earnings, then I think the analysts could have adjusted their estimates and Vivus' stock price would have traded lower but not crashed and nobody would have been caught with their pants to their ankles.

Vivus can now only recover via a buyout or a few quarters of productive earnings otherwise I am not holding my breath for the forgiveness.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News